The Thermo Fisher Scientific Accula system is a rapid diagnostic point of care platform that provides simple, accurate sample-to-answer rapid PCR. Using a palm-sized Accula Dock in a CLIA waived environment, the Accula rapid PCR Tests provides reliable, qualitative PCR results in 30 minutes.
NOTE: Testing for the Accula SARS-CoV-2 Test is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet requirements to perform high, moderate, or waived complexity tests. The Accula SARS-CoV-2 Test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
A CLIA Certificate of waiver number is required prior to order fulfillment.